| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10001741 | HBV | ENSG00000162383.13 | protein_coding | SLC1A7 | No | No | 6512 | A0A087WUF9 F1T0D3 F1T0D4 O00341 |
| TVIS10014626 | HBV | ENSG00000162383.13 | protein_coding | SLC1A7 | No | No | 6512 | A0A087WUF9 F1T0D3 F1T0D4 O00341 |
| TVIS10014627 | HBV | ENSG00000162383.13 | protein_coding | SLC1A7 | No | No | 6512 | A0A087WUF9 F1T0D3 F1T0D4 O00341 |
| TVIS10023494 | HBV | ENSG00000162383.13 | protein_coding | SLC1A7 | No | No | 6512 | A0A087WUF9 F1T0D3 F1T0D4 O00341 |
| TVIS10025831 | HBV | ENSG00000162383.13 | protein_coding | SLC1A7 | No | No | 6512 | A0A087WUF9 F1T0D3 F1T0D4 O00341 |
| TVIS30079478 | HIV | ENSG00000162383.13 | protein_coding | SLC1A7 | No | No | 6512 | A0A087WUF9 F1T0D3 F1T0D4 O00341 |
| TVIS30084921 | HIV | ENSG00000162383.13 | protein_coding | SLC1A7 | No | No | 6512 | A0A087WUF9 F1T0D3 F1T0D4 O00341 |
| TVIS20047784 | HPV | ENSG00000162383.13 | protein_coding | SLC1A7 | No | No | 6512 | A0A087WUF9 F1T0D3 F1T0D4 O00341 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | SLC1A7 |
|---|---|
| DrugBank ID | DB00142 |
| Drug Name | Glutamic acid |
| Target ID | BE0002267 |
| UniProt ID | O00341 |
| Regulation Type | |
| PubMed IDs | 17139284; 17016423; 15128272; 9108121 |
| Citations | Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.@@Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.@@Takarada T, Hinoi E, Balcar VJ, Taniura H, Yoneda Y: Possible expression of functional glutamate transporters in the rat testis. J Endocrinol. 2004 May;181(2):233-44.@@Arriza JL, Eliasof S, Kavanaugh MP, Amara SG: Excitatory amino acid transporter 5, a retinal glutamate transporter coupled to a chloride conductance. Proc Natl Acad Sci U S A. 1997 Apr 15;94(8):4155-60. |
| Groups | Approved; Nutraceutical |
| Direct Classification | Glutamic acid and derivatives |
| SMILES | N[C@@H](CCC(O)=O)C(O)=O |
| Pathways | Histidinemia; Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency); 3-Methylglutaconic Aciduria Type I; beta-Ketothiolase Deficiency; Purine Nucleoside Phosphorylase Deficiency; Tyrosine Metabolism; Ketoprofen Action Pathway; Glutamate Metabolism; Argininosuccinic Aciduria; Salla Disease/Infantile Sialic Acid Storage Disease; Tyrosinemia Type I; Hyperinsulinism-Hyperammonemia Syndrome; 2-Methyl-3-hydroxybutryl-CoA Dehydrogenase Deficiency; Glutaric Aciduria Type I; Propanoate Metabolism; Celecoxib Action Pathway; Glycine and Serine Metabolism; Suprofen Action Pathway; Indomethacin Action Pathway; Carbamoyl Phosphate Synthetase Deficiency; Sialuria or French Type Sialuria; Ibuprofen Action Pathway; Saccharopinuria/Hyperlysinemia II; Histidine Metabolism; Arginine and Proline Metabolism; Purine Metabolism; Diflunisal Action Pathway; Etodolac Action Pathway; Ammonia Recycling |
| PharmGKB | PA449776 |
| ChEMBL | CHEMBL575060 |
